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Case of bullous pemphigoid in a 28-year-old woman affected
by tuberous sclerosis complex
Dear Editor,
A 28-year-old woman accompanied by her mother was
referred to our department for evaluation of an erythematous
pruritic plaque of the left leg. A diagnosis of tuberous sclerosis
complex (TSC) was made at the age of 2 years. Molecular
analysis revealed a sporadic mutation in the TSC-2 gene,
which is localized on the short arm of chromosome 16 (16p13)
and encode for tuberin. Although no epileptic attack had been
observed since the age of 15 years, the patient continued with
prophylactic anticonvulsant therapy with vigabatrin. In our
patient, the TSC is associated with autism with a severe grade
of intellectual disability. Her medical reports described the
presence of cortical dysplasias, retinal hamartomas, dental
enamel pits and intraoral pits. In October 2006, at the age of
19 years, after bilateral nephrectomy due to polycystic kidneys
related to TSC, the patient received a renal graft transplant
from a deceased donor. After kidney transplantation she took
mycophenolate mofetil without side-effects or transplant rejec-
tion. The mother reported that the erythematous plaque of the
left leg was mildly itchy and appeared 6 months before the
visit. Physical examination revealed a tense bulla on the ery-
thematous plaque of the left leg (Fig. 1a) and the presence of
Figure 1. The patient had a tense bulla on an erythematous
pruritic plaque of the (a) left leg and (b) facial angiofibromas.
(c) Reflectance confocal microscopy (RCM) performed on the
tense bulla of the left leg revealed substantially normal superfi-
cial layers of the epidermis and the presence of a mild spon-
giosis that appeared as a darker area, compared with the
surrounding epithelium with increased intercellular spaces, in
which were present bright and pinpoint structures correspond-
ing to inflammatory cells (green arrows). (d) RCM showed at
the level of the dermoepidermal junction (DEJ) the presence of
a dark, ovoid to round, well-demarcated area filled by some
bright and pinpoint structures, which correspond on histology
to the subepidermal bulla (+) with some inflammatory cells
inside (green arrows). Furthermore, RCM revealed the presence
of mildly refractive homogeneous material inside of this dark
area that appeared like grayish material corresponding to fibrin
deposition (blue arrows). (e,f) Instead, RCM executed on the
healthy skin surface adjacent to the erythematous plaque
showed normal layered architecture of the skin. (g) Optical
coherence tomography (OCT) performed on the tense bulla of
the left leg revealed the presence of subepidermal bulla (+) that
appeared like dark, ovoid to round, well-demarcated lobule at
the level of the DEJ. Furthermore, some inflammatory cells
(green arrows), which looked like grey pinpoint structures, infil-
trated the cleft and this may be reflected as more grayish
appearance of the bulla in the OCT image. Moreover, OCT
showed the presence of fibrin deposit (blue arrows) inside the
subepidermal cleft that appeared like grayish homogeneous
material. (h) Instead, OCT executed on the healthy skin surface
adjacent to the erythematous plaque showed the normal lay-
ered architecture of the skin. (g,h) The stratum corneum, epi-
dermis and DEJ are marked by white arrows. (i)
Histopathological findings of the skin biopsy revealed at the
level of the DEJ a subepidermal bulla with some inflammatory
cells and fibrin deposition inside, an infiltrate of inflammatory
cells with many eosinophils in the upper dermis and a mild
spongiosis with variable amount of inflammatory cells between
epidermal keratinocytes (hematoxylin–eosin, original magnifica-
tion 910). (j) Direct immunofluorescence showed immunoglob-
ulin (Ig)G and C3 deposit to the DEJ, while IgM and IgA were
negative. (m) Indirect immunofluorescence revealed antibodies
directed to the DEJ with a titer of 1:40. (n) After 4 months of
topical corticosteroid therapy, we observed the presence of
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facial angiofibromas (Fig. 1b) related to TSC, while did not
reveal other skin or mucosal lesions. The mother reported that
a few days before the visit she noticed for the first time the
appearance of a blister. Clinical examination along with reflec-
tance confocal microscopy (RCM) (Vivascope 3000; Caliber
I.D., Rochester, NY, USA) and optical coherence tomography
(OCT) (VivoSight; Michelson Diagnostics, Maidstone, UK) per-
formed on the tense bulla of the left leg suggested a diagnosis
of bullous pemphigoid (BP) (Fig. 1c,d,g).1,2 Instead, RCM and
OCT executed on the healthy skin surface adjacent to the ery-
thematous plaque showed normal layered architecture of the
skin (Fig. 1e,f,h). Then, we executed indirect immunofluores-
cence and two biopsies, one for histopathological examination
and one for direct immunofluorescence. Histopathological
examination confirmed our diagnostic suspicion (Fig. 1i). Direct
immunofluorescence showed immunoglobulin (Ig)G and C3
deposit to the dermoepidermal junction (DEJ) (Fig. 1l). Indirect
immunofluorescence revealed antibodies directed to the DEJ
with a titer of 1:40 (Fig. 1m). Moreover, we performed enzyme-
linked immunoassay (ELISA) test: anti-BP180 IgG 106.89 U/mL
and anti-BP230 IgG 1.20 U/mL. Based on all these findings, a
diagnosis of BP was made. The patient subsequently under-
went only topical corticosteroid therapy with clobetasol propi-
onate 0.05% cream that was tapered over 4 months: every
day in the first month, every other day in the second month,
twice a week in the third month and once a week in the fourth
month. After the end of the therapy, we observed the presence
of milia and post-inflammatory pigmentation (Fig. 1n). In
2 years of follow up, there was no evidence of relapse or any
additional lesion on other sites. In the published work, to the
best of our knowledge, the association between BP and TSC is
not reported.3–5 We did not find a correlation between BP and
TSC, and we think that the occurrence of both diseases in a sin-
gle individual is only accidental and extremely rare.
Written informed consent was obtained from the patient’s
legal guardian(s) (including the patient’s mother) for publication
of this case report and any accompanying images. A copy of
the written consent is available for review by the Editor-in-Chief
of this journal.
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Chemotherapy-induced inflammation of seborrheic keratoses
due to pemetrexed treatment
Dear Editor,
Inflammation of seborrheic keratoses (ISK) is a rare adverse
cutaneous reaction to chemotherapy. It is characterized by the
inflammation of existing seborrheic keratosis (SK) after the
administration of chemotherapy.1 Here, we report two cases of
ISK induced by pemetrexed. This is the first report about
pemetrexed-induced ISK.
Case 1 involved a 75-year-old Japanese woman with lung
cancer who developed numerous pruritic rashes 7 days after
the injection of pemetrexed. A physical examination revealed
inflammatory erythema, which was confined to multiple small
brown papules on her neck and upper chest (Fig. 1a,b). A
histopathological examination detected numerous infiltrates of
lymphocytes and eosinophils in the upper dermis around SK
(Fig. 1c,d). The number of infiltrated CD4+ and CD8+ cells were
approximately the same (data not shown). The SK at other
sites were not inflamed. The erythema around the SK subsided
7 days after difluprednate ointment treatment (Fig. 1e,f). The
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